AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany.

Espervita Therapeutics is a developer of metabolic reprogramming therapies used for the treatment of cancers. Its therapies focus on the areas with a significant unmet medical need such as the treatment for liver cancer amongst others to help medical professionals to have therapeutic expertise to prevent cancer cell proliferation, increase immune detection, and reduce tumor burden. The company was founded in 2018 and is headquartered in Saline, Michigan.

Manufactures and sells pharmaceuticals

Part of Jazz Pharmaceuticals Plc, GW Research Ltd. is a company headquartered in Cambridge, UK. The firm engages in researching and developing biotechnology. It was founded in 1995.

Hudson Institute of Medical Research is an independent, not-for-profit medical research institute, based in the Melbourne suburb of Clayton in Victoria. The Institute hosts approximately 450 researchers, postgraduate students and support staff. Research at Hudson Institute works to understand, prevent and treat women’s and baby health, cancer, innate immunity and infectious diseases, and reproductive health.

Secarna Pharmaceuticals Gmbh & Co. is a private company headquartered in Germany. The firm operates as drug discovery company.\nThe company says this about itself: Secarna Pharmaceuticals is the leading independent European next-generation antisense drug discovery and development company addressing high unmet medical needs in immuno-oncology, immunology, as well as viral, neurodegenerative and cardiometabolic diseases. Secarna's mission is to maximize the performance and output of its proprietary LNAplus TM antisense oligonucleotide discovery platform, as well as to develop highly specific, safe, and efficacious best-in-class antisense therapies. With over 15 development programs, including both proprietary pipeline projects and partnered programs, Secarna focuses on targets in indications where antisense-based approaches have clear potential benefits over other therapeutic modalities.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. It was formed by Apple Tree Partners in 2022.

Todos Medical Ltd. is an in vitro diagnostics company. It is focused on the development of novel blood tests for the early detection of cancer and Alzheimer's disease, and the distribution of comprehensive solutions for COVID-19 screening. It is also involved in the activities of breast cancer test, such as TM-B1 and TM-B2. The company was founded by Rami Zigdon and Udi Zelig on April 22, 2010 and is headquartered in Tel Aviv, Israel.

Biocompatibles UK Ltd. is a company headquartered in Farnham, UK, that manufactures, and markets implantable products for patients. The firm was founded in 2001.

Beijing Origin Juhe Biotechnology Co., Ltd., established on 2020-07-27, Business scope includes technical promotion services;Import and export;Technology Import and Export;Agent import and export;software development;Business Management Consulting;Conference Services;Production of class Ι medical devices;Sales Ι,Class II medical device,computer,Software and Auxiliary Equipment;Educational Consulting;Medical Research(Does not include medical activities);health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);Sales of Class III Medical Devices;Production of the second class,Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of the second class,Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.).

Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China.

Dongguk University Industry-Academic Cooperation Foundation is for the promotion of tenants and entrepreneurship.

Beijing Angke Future Medical Equipment Co., Ltd., established on 2018-03-20, Business scope includes sales of Class I medical devices,Class II medical device,Professional setting,General Equipment,Chemical Products(Free of dangerous chemicals and precursor drugs);Medical Research and Experimental Development;technology development,technical consulting,technology transfer,Technical Services,Technology Promotion;Economic and Trade Consulting;Conference Services;Undertake exhibition and display activities;Import and export,Agent import and export,Technology Import and Export;Sales of Class III Medical Devices.(Enterprises independently choose operating projects according to law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Nanjing Tengchen Biotechnology Co., Ltd., established on 2018-03-29, The scope of business includes the development of biotechnology,technology transfer,technical consulting,Technical Services,Testing service;Health Management Consulting Services;medical service;Medical device research and development,Production,Sales,transfer,Technical Consulting and Technical Services;Data Processing and Storage Services;Research and development of laboratory equipment,Production,processing,Sales,Technical Consulting and Technical Services;Computer Technology Development and Services;R&D and sales of chemical raw materials and products and biological reagents;laboratory consumables,Instrumentation,Sales of Electronics;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)